首页>
外国专利>
PHARMACEUTICAL COMPOSTION FOR ACUTE PHASE PROTEIN TARGETED TREATMENT OF ACUTE AND CHRONIC DYSREGULATED INFLAMMATORY DISEASES OR CONDITIONS
PHARMACEUTICAL COMPOSTION FOR ACUTE PHASE PROTEIN TARGETED TREATMENT OF ACUTE AND CHRONIC DYSREGULATED INFLAMMATORY DISEASES OR CONDITIONS
展开▼
机译:急性阶段性和慢性失调的炎症性疾病或病状的急性相蛋白靶向治疗的药物组合物
展开▼
页面导航
摘要
著录项
相似文献
摘要
Disclosed is a Pharmaceutical composition containing as an active ingredient an effective amount of inhibitors of SAA, CRP and/or CXCL-1 activity, or a pharmaceutically acceptable salt for the use in the treatment of dysregulated inflammatory diseases or conditions and/or malignancies and/or cancer and/or tumors by influencing the activity of myeloid-derived suppressor cells (MDSC), as well as the use of an effective amount of inhibitors of SAA, CRP and/or CXCL-1 activity or a pharmaceutically acceptable salt thereof for reducing the frequency, accumulation and/or activity, and/or for depleting MDSC for treating diseases or conditions and a Method for the treatment of malignancies and/or cancer and/or tumors in individuals by administering an effective amount of an inhibitor of SAA, CRP and/or CXCL-1 or a pharmaceutically acceptable salt thereof.
展开▼